Schedule of deferred tax assets and liabilities |
Schedule of deferred tax assets and liabilities
|
|
|
|
|
|
|
|
|
March
31,
2023
|
|
|
December 31, 2022
|
|
Deferred tax assets |
|
|
|
|
|
|
|
|
Net operating losses |
|
$ |
10,206,155 |
|
|
$ |
9,106,430 |
|
Depreciation and intangible assets |
|
|
1,763,042 |
|
|
|
1,502,868 |
|
Research & development credit |
|
|
1,457,766 |
|
|
|
1,308,956 |
|
Lease liability |
|
|
304,100 |
|
|
|
322,167 |
|
Inventory |
|
|
1,283,975 |
|
|
|
1,290,968 |
|
Stock-based compensation |
|
|
3,196,761 |
|
|
|
3,103,037 |
|
Accrued expenses |
|
|
416,063 |
|
|
|
233,284 |
|
Capital loss carryover |
|
|
276,522 |
|
|
|
261,922 |
|
Other |
|
|
11,962 |
|
|
|
177,074 |
|
Total |
|
|
18,916,346 |
|
|
|
17,306,705 |
|
Valuation allowance |
|
|
(18,223,498 |
) |
|
|
(16,661,612 |
) |
Net deferred tax asset |
|
|
692,848 |
|
|
|
645,093 |
|
Deferred tax liabilities |
|
|
|
|
|
|
|
|
Prepaid expenses |
|
|
(395,503 |
) |
|
|
(328,836 |
) |
Right-of-use assets |
|
|
(297,345 |
) |
|
|
(316,257 |
) |
Total net deferred taxes deferred tax liabilities |
|
$ |
– |
|
|
$ |
– |
|
|